Brunacol may be available in the countries listed below.
Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Brunacol in the following countries:
International Drug Name Search
Citalopram Depronal may be available in the countries listed below.
Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram Depronal in the following countries:
International Drug Name Search
Generic Name: denosumab (Xgeva) (den OH sue mab)
Brand Names: Xgeva
Denosumab is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.
The Xgeva brand of denosumab is used to prevent bone fractures and other skeletal conditions in people with tumors that have spread to the bone. Xgeva is not for use in people with multiple myeloma (bone marrow cancer).
This medication guide provides information about the Xgeva brand of denosumab. Prolia is another brand of denosumab used to treat osteoporosis in postmenopausal women who have high risk of bone fracture.
Denosumab may also be used for purposes not listed in this medication guide.
This medication guide provides information about the Xgeva brand of denosumab. Prolia is another brand of denosumab used to treat osteoporosis in postmenopausal women who have high risk of bone fracture.
Before you receive this medication, tell your doctor if you have kidney disease or if you are on dialysis.
Some people using denosumab have developed bone loss in the jaw, also called osteonecrosis of the jaw. Symptoms may include jaw pain, swelling, numbness, loose teeth, gum infection, or slow healing after injury or surgery involving the gums. You may be more likely to develop osteonecrosis of the jaw if you have cancer or have been treated with chemotherapy, radiation, or steroids. Other conditions associated with osteonecrosis of the jaw include blood clotting disorders, anemia (low red blood cells), and a pre-existing dental problem.
To make sure you can safely use Xgeva, tell your doctor if you have kidney disease or if you are on dialysis.
Some people using denosumab have developed bone loss in the jaw, also called osteonecrosis of the jaw. Symptoms may include jaw pain, swelling, numbness, loose teeth, gum infection, or slow healing after injury or surgery involving the gums. You may be more likely to develop osteonecrosis of the jaw if you have cancer or have been treated with chemotherapy, radiation, or steroids. Other conditions associated with osteonecrosis of the jaw include blood clotting disorders, anemia (low red blood cells), and a pre-existing dental problem.
Denosumab is injected under the skin of your stomach, upper thigh, or upper arm. A healthcare provider will give you this injection.
Xgeva is usually given once every 4 weeks. Follow your doctor's instructions.
Your doctor may have you take extra calcium and vitamin D while you are being treated with denosumab. Take only the amount of calcium and vitamin D that your doctor has prescribed.
Pay special attention to your dental hygiene. Brush and floss your teeth regularly while receiving this medication. You may need to have a dental exam before you begin treatment with Xgeva. Follow your doctor's instructions.
You may take the medicine out of the refrigerator and allow it to reach room temperature before giving the injection. Do not heat the medicine before using.
Each single use vial (bottle) of this medicine is for one use only. Throw away after one use, even if there is still some medicine left in it after injecting your dose.
Call your doctor for instructions if you miss an appointment for your Xgeva injection.
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
numbness or tingly feeling around your mouth or in your fingers or toes, fast or slow heart rate, muscle cramps or contraction, overactive reflexes; or
trouble breathing.
Less serious side effects may include:
feeling weak or tired;
diarrhea, nausea; or
headache.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Osteoporosis:
For the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy, treatment to increase bone mass in women at high risk for fracture
receiving adjuvant aromatase inhibitor therapy for breast cancer, and treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer:
60 mg administered as a single subcutaneous injection in the upper arm, the upper thigh, or the abdomen once every 6 months. All patients should receive calcium 1000 mg daily and at least 400 IU vitamin D daily
Usual Adult Dose for Hypercalcemia of Malignancy:
For the prevention of skeletal related events in patients with bone metastases from solid tumors:
120 mg as a subcutaneous injection in the upper arm, upper thigh, or abdomen every 4 weeks.
Administer calcium and vitamin D as necessary to treat or prevent hypocalcemia.
There may be other drugs that can interact with Xgeva. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: denosumab side effects (in more detail)
Doabetic may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Doabetic in the following countries:
International Drug Name Search
Leustat may be available in the countries listed below.
UK matches:
Cladribine is reported as an ingredient of Leustat in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Metronidazole Teva may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazole Teva in the following countries:
International Drug Name Search
Diseptyl may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Diseptyl in the following countries:
Trimethoprim is reported as an ingredient of Diseptyl in the following countries:
International Drug Name Search
Metronidazol Genericon may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazol Genericon in the following countries:
International Drug Name Search
Ibuphil may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuphil in the following countries:
International Drug Name Search
Tamoa may be available in the countries listed below.
Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Tamoa in the following countries:
International Drug Name Search
Co-Trimoxazol PCH may be available in the countries listed below.
Sulfamethoxazole is reported as an ingredient of Co-Trimoxazol PCH in the following countries:
Trimethoprim is reported as an ingredient of Co-Trimoxazol PCH in the following countries:
International Drug Name Search
Noax may be available in the countries listed below.
Tramadol is reported as an ingredient of Noax in the following countries:
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Noax in the following countries:
International Drug Name Search
Cortamethasone may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dexamethasone is reported as an ingredient of Cortamethasone in the following countries:
International Drug Name Search
StrontPol may be available in the countries listed below.
Strontium Chloride Sr 89 is reported as an ingredient of StrontPol in the following countries:
International Drug Name Search
Ciprofloxacina Ciclum may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Ciprofloxacina Ciclum in the following countries:
International Drug Name Search
Cloxi-Z may be available in the countries listed below.
Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Cloxi-Z in the following countries:
International Drug Name Search
Cervagem may be available in the countries listed below.
Gemeprost is reported as an ingredient of Cervagem in the following countries:
International Drug Name Search
Meclophen may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Meclophen in the following countries:
International Drug Name Search
Molasic may be available in the countries listed below.
Mefenamic Acid is reported as an ingredient of Molasic in the following countries:
International Drug Name Search
Metformina Generis may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformina Generis in the following countries:
International Drug Name Search
Antiparasit Flash may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dimpylate is reported as an ingredient of Antiparasit Flash in the following countries:
International Drug Name Search
Kalium-R may be available in the countries listed below.
Potassium Chloride is reported as an ingredient of Kalium-R in the following countries:
International Drug Name Search
In the US, Ketek (telithromycin systemic) is a member of the drug class ketolides and is used to treat Bronchitis, Pneumonia, Sinusitis and Tonsillitis/Pharyngitis.
US matches:
UK matches:
Telithromycin is reported as an ingredient of Ketek in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Lomezec may be available in the countries listed below.
Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Lomezec in the following countries:
International Drug Name Search
Glucoferro-K may be available in the countries listed below.
Ferrous Gluconate is reported as an ingredient of Glucoferro-K in the following countries:
International Drug Name Search
Novecin may be available in the countries listed below.
Ofloxacin is reported as an ingredient of Novecin in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Prop.INN
B03BA04
0013870-90-1
C72-H100-Co-N18-O17-P
1579
Vitamin B₁₂
5'-Deoxyadenosylcobolamine
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Prop.INN | Proposed International Nonproprietary Name (World Health Organization) |
Donepezil Krka may be available in the countries listed below.
Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donepezil Krka in the following countries:
International Drug Name Search
Pirisudanolo may be available in the countries listed below.
Pirisudanolo (DCIT) is also known as Pirisudanol (Rec.INN)
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Guaifenesin (glyceryl guaiacolate) has the chemical name 3-(2-methoxyphenoxy)-1,2-propanediol. Its molecular formula is C10H14O4 with a molecular weight of 198.21. It is a white or slightly gray crystalline substance with a slightly bitter aromatic taste. One gram dissolves in 20 mL water at 25°C; it is freely soluble in ethanol. Guaifenesin is readily absorbed from the GI tract and is rapidly metabolized and excreted in the urine. Guaifenesin has a plasma half-life of one hour. The major urinary metabolite is β-(2-methoxyphenoxy) lactic acid.
ORGANIDIN® NR (guaifenesin) is an expectorant available for oral administration as:
Tablets — each containing 200 mg guaifenesin, USP.
Other ingredients: Corn starch, croscarmellose sodium, FD&C Red No. 40, magnesium stearate, microcrystalline cellulose.
ORGANIDIN® NR (guaifenesin) is an expectorant, the action of which promotes or facilitates the removal of secretions from the respiratory tract. By increasing sputum volume and making sputum less viscous, guaifenesin facilitates expectoration of retained secretions.
ORGANIDIN® NR: Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, drain bronchial tubes and make coughs more productive. Helps loosen phlegm and thin bronchial secretions in patients with stable chronic bronchitis.
Hypersensitivity to any of the ingredients.
Carcinogenesis, Mutagenesis, Impairment of Fertility: Animal studies to assess the long-term carcinogenic and mutagenic potential or the effect on fertility in animals or humans have not been performed.
Pregnancy:
Teratogenic Effects—Pregnancy Category C: Animal reproduction studies have not been conducted. Safe use in pregnancy has not been established relative to possible adverse effects on fetal development. Therefore, these products should not be used in pregnant patients unless, in the judgment of the physician, the potential benefits outweigh possible hazards.
Nursing Mothers: It is not known whether guaifenesin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when these products are administered to a nursing woman and a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Laboratory Test Interactions: Guaifenesin or its metabolites may cause color interference with the VMA (vanillylmandelic acid) test for catechols. It may also falsely elevate the level of urinary 5-HIAA (5-hydroxyindoleacetic acid) in certain serotonin metabolite chemical tests because of color interference.
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Guaifenesin is well tolerated and has a wide margin of safety. Side effects have been generally mild and infrequent. Nausea and vomiting are the side effects that occur most commonly. Dizziness, headache, and rash (including urticaria) have been reported rarely.
In massive overdosage the stomach should be emptied (emesis and/or gastric lavage) and further absorption prevented. Treatment is symptomatic and supportive.
The acute toxicity of guaifenesin is low and overdosage is unlikely to produce serious toxic effects. In laboratory animals no toxicity resulted when guaifenesin was administered by stomach tube in doses up to 5 grams/kg.
ORGANIDIN® NR (guaifenesin)
Tablets — Adults and children 12 years of age and older: One to 2 tablets (200 mg to 400 mg) every four hours, not to exceed 2400 mg (12 tablets) in 24 hours.
PATIENTS SHOULD BE ADVISED TO KEEP THESE AND ALL DRUGS OUT OF THE REACH OF CHILDREN AND TO SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY IN CASE OF ACCIDENTAL OVERDOSE.
ORGANIDIN® NR (guaifenesin)
Tablets — Each round, scored, rose-colored tablet contains 200 mg guaifenesin USP—available in bottles of 100 (NDC 0037-4312-01)
STORAGE — Store at controlled room temperature 20°-25°C (68°-77°F). Protect tablets from moisture. Keep bottle tightly closed.
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
MEDA PHARMACEUTICALS
Meda Pharmaceuticals Inc.
Somerset, New Jersey 08873-4120
IN-046J2-08 Rev. 11/09
Package Label - Principal Display Panel – 100 Tablet Bottle, Organidin NR Tablets
NDC 0037-4312-01
100 Tablets
Organidin® NR
Tablets (guaifenesin)
Expectorant
Each tablet§ contains:
Guaifenesin USP 200 mg
Other ingredients: croscarmellose sodium,
FD&C Red #40, magnesium stearate,
microcrystalline cellulose, starch.
§Assayed by a procedure other than that
specified in the USP.
This product labeled for dispensing on
prescription only.
Meda
Pharmaceuticals®
LB-046J2-06 Rev. 1/09
See package insert for dosing
information and directions for use.
Store at controlled room
temperature 20°-25°C
(68°-77°F).
Protect from moisture.
Dispense in tight container.
Meda Pharmaceuticals®
Meda Pharmaceuticals Inc.
Somerset, New Jersey 08873-4120
| ORGANIDIN NR guaifenesin tablet | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Unapproved drug other | 09/01/1995 | 08/31/2013 | |
| ORGANIDIN NR guaifenesin liquid | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Unapproved drug other | 09/01/1995 | 09/30/2010 | |
| Labeler - Meda Pharmaceuticals Inc. (051229602) |
Azithromycin 1A Farma may be available in the countries listed below.
Azithromycin monohydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin 1A Farma in the following countries:
International Drug Name Search
In the US, Tace (chlorotrianisene systemic) is a member of the drug class estrogens and is used to treat Menopausal Disorders, Primary Ovarian Failure and Prostate Cancer.
US matches:
Levonorgestrel is reported as an ingredient of Tace in the following countries:
International Drug Name Search
Manudine may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Manudine in the following countries:
International Drug Name Search
Foliment may be available in the countries listed below.
Calcium Folinate is reported as an ingredient of Foliment in the following countries:
International Drug Name Search
Memo-Farmellas may be available in the countries listed below.
Galantamine hydrobromide (a derivative of Galantamine) is reported as an ingredient of Memo-Farmellas in the following countries:
International Drug Name Search
Propitan may be available in the countries listed below.
Pipamperone dihydrochloride (a derivative of Pipamperone) is reported as an ingredient of Propitan in the following countries:
International Drug Name Search
Rheumacin may be available in the countries listed below.
Indometacin is reported as an ingredient of Rheumacin in the following countries:
International Drug Name Search
Corator may be available in the countries listed below.
Atorvastatin is reported as an ingredient of Corator in the following countries:
International Drug Name Search
Atenolol Calox may be available in the countries listed below.
Atenolol is reported as an ingredient of Atenolol Calox in the following countries:
International Drug Name Search
Canalac may be available in the countries listed below.
Lactulose is reported as an ingredient of Canalac in the following countries:
International Drug Name Search
Clovexil may be available in the countries listed below.
Clopidogrel is reported as an ingredient of Clovexil in the following countries:
International Drug Name Search
Glucomed may be available in the countries listed below.
Glucosamine hydrochloride (a derivative of Glucosamine) is reported as an ingredient of Glucomed in the following countries:
International Drug Name Search
Sterakfin may be available in the countries listed below.
Finasteride is reported as an ingredient of Sterakfin in the following countries:
International Drug Name Search
Erythrodar may be available in the countries listed below.
Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erythrodar in the following countries:
International Drug Name Search
Hidrocortisona Northia may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Hidrocortisona Northia in the following countries:
International Drug Name Search
Pirexyl may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Pirexyl in the following countries:
International Drug Name Search
Cholvastin may be available in the countries listed below.
Lovastatin is reported as an ingredient of Cholvastin in the following countries:
International Drug Name Search
Cefmetazon may be available in the countries listed below.
Cefmetazole sodium salt (a derivative of Cefmetazole) is reported as an ingredient of Cefmetazon in the following countries:
International Drug Name Search
Corticorelin Ovine Triflutate may be available in the countries listed below.
Corticorelin Ovine Triflutate (USAN) is known as Corticorelin in the US.
International Drug Name Search
Glossary
| USAN | United States Adopted Name |
Biotaksym may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Biotaksym in the following countries:
International Drug Name Search
In the US, Cerivastatin (cerivastatin systemic) is a member of the drug class statins and is used to treat High Cholesterol and Hyperlipoproteinemia Type IIa - Elevated LDL.
US matches:
Rec.INN
C10AA06
0145599-86-6
C26-H34-F-N-O5
459
Antilipemic agent, HMG CoA reductase inhibitor (statin)
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-[S-[R*,S*-(E)]]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Hydrocortison may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Hydrocortison in the following countries:
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Hydrocortison in the following countries:
International Drug Name Search
Broomhexine Hydrochloride may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Broomhexine Hydrochloride in the following countries:
International Drug Name Search
Husten ACC Hexal may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Husten ACC Hexal in the following countries:
International Drug Name Search
Midazolam Normon may be available in the countries listed below.
Midazolam is reported as an ingredient of Midazolam Normon in the following countries:
International Drug Name Search
Thriusedon may be available in the countries listed below.
Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Thriusedon in the following countries:
International Drug Name Search
Lipira may be available in the countries listed below.
Gemfibrozil is reported as an ingredient of Lipira in the following countries:
International Drug Name Search
Piptalin may be available in the countries listed below.
Pipenzolate Bromide is reported as an ingredient of Piptalin in the following countries:
International Drug Name Search
Chlortétracycline Vétoquinol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of Chlortétracycline Vétoquinol in the following countries:
International Drug Name Search
Donethon may be available in the countries listed below.
Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Donethon in the following countries:
International Drug Name Search
Zerodol may be available in the countries listed below.
Aceclofenac is reported as an ingredient of Zerodol in the following countries:
International Drug Name Search
Quitoso may be available in the countries listed below.
Permethrin is reported as an ingredient of Quitoso in the following countries:
International Drug Name Search
Cortispec may be available in the countries listed below.
Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Cortispec in the following countries:
International Drug Name Search
Osteonorm may be available in the countries listed below.
Calcitonin is reported as an ingredient of Osteonorm in the following countries:
Clodronic Acid disodium tetrahydrate (a derivative of Clodronic Acid) is reported as an ingredient of Osteonorm in the following countries:
International Drug Name Search
Elyzol may be available in the countries listed below.
Metronidazole is reported as an ingredient of Elyzol in the following countries:
Metronidazole benzoate (a derivative of Metronidazole) is reported as an ingredient of Elyzol in the following countries:
International Drug Name Search
Nafoxal may be available in the countries listed below.
Naftidrofuryl oxalate (a derivative of Naftidrofuryl) is reported as an ingredient of Nafoxal in the following countries:
International Drug Name Search
ROE-ta-vye-rus VAX-een, lyve
In the U.S.
Available Dosage Forms:
Therapeutic Class: Vaccine
Rotavirus vaccine live is used to prevent infants and children from getting a rotavirus stomach infection. It works by causing your body to produce its own protection (antibodies) against the virus.
Rotavirus is a serious infection that causes diarrhea and vomiting. It may also cause severe dehydration in infants and children.
This vaccine is to be administered only by or under the supervision of your child's doctor.
In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to rotavirus vaccine, live or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of live rotavirus vaccine in infants younger than 6 weeks of age or older than 24 weeks of age. Safety and efficacy have not been established.
No information is available on the relationship of age to the effects of live rotavirus vaccine in geriatric patients.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this vaccine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Receiving this vaccine with any of the following medicines is not recommended. Your doctor may decide not to use this vaccine or change some of the other medicines you take.
Receiving this vaccine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Receiving this vaccine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:
A nurse or other trained health professional will give your child this vaccine. It is given by mouth.
rotavirus vaccine, live needs to be given on a fixed schedule. If your child missed the scheduled dose, call your child’s doctor for another appointment.
rotavirus vaccine, live comes with a patient information leaflet. Read the information carefully. Ask your doctor if you have any questions.
The dose of rotavirus vaccine, live will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rotavirus vaccine, live. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
It is very important that your child's doctor check your child's progress at regular visits to make sure that this vaccine is working properly and to check for unwanted effects.
Make sure your child's doctor knows if your child is receiving medicine or a procedure that may weaken the immune system, such as steroids, cancer medicines, or radiation. Tell your child's doctor if your child spends time with a person who has an immune system problem or is getting cancer medicines.
The oral applicator of this vaccine contains dry natural latex rubber. Make sure your child's doctor knows if your child has had an allergic reaction to latex rubber.
Call your child's doctor right away if your child has diarrhea, blood in the stool, a high fever, severe stomach pain, or vomiting. These could be symptoms of a serious bowel problem called intussusception.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
In the US, Kabikinase is a member of the drug class thrombolytics and is used to treat Arterial Thrombosis, Deep Vein Thrombosis, Heart Attack, Pulmonary Embolism and Thrombotic/Thromboembolic Disorder.
Streptokinase is reported as an ingredient of Kabikinase in the following countries:
International Drug Name Search
Chlortalidone EG may be available in the countries listed below.
Chlortalidone is reported as an ingredient of Chlortalidone EG in the following countries:
International Drug Name Search
Allernothin may be available in the countries listed below.
Epinastine hydrochloride (a derivative of Epinastine) is reported as an ingredient of Allernothin in the following countries:
International Drug Name Search
S-Mez may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfadimidine sodium salt (a derivative of Sulfadimidine) is reported as an ingredient of S-Mez in the following countries:
International Drug Name Search
Sucralfaat Katwijk may be available in the countries listed below.
Sucralfate is reported as an ingredient of Sucralfaat Katwijk in the following countries:
International Drug Name Search
Monosordil may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Monosordil in the following countries:
International Drug Name Search
Nalbuphin Orpha may be available in the countries listed below.
Nalbuphine hydrochloride (a derivative of Nalbuphine) is reported as an ingredient of Nalbuphin Orpha in the following countries:
International Drug Name Search
